YEM Search

搜索结果

EIF2AK4

靶点ID:TCMBANKGE000769

靶点别名:GCN2; PVOD2

靶点描述:eukaryotic translation initiation factor 2 alpha kinase 4

染色体:15

染色体位置:15q15.1

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:19687

OMIM_Link:609280

Ensembl_Link:ENSG00000128829

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN019471	methylglyoxal	Propanal, 2-oxo-; FT-0646558; CH3COCHO; oxopropanal; Propionaldehyde, 2-keto; Pyruvaldehyde solution; Pyroracemic aldehyde; alpha-Ketopropionaldehyde; 78-98-8; D07QPX; NSC-133493; 51252-84-7; Methylglyoxal solution, technical, ~40% in H2O; H451; RP00358; Propanedione; I14-13930; NSC626580; F0001-2060; PVL; pyruvaldehyde; NSC-133492; 2-oxopropanoyl; 2-Ketopropionaldehyde; Methylglyoxal solution; 2-Oxopropanal; D0G4CI; Ketopropionaldehyde; Pyruvoyl Group; ANW-37250; METHYL GLYOXAL; pyruvic aldehyde; 2-oxo-Propionaldehyde; Propanolone; KSC377C2D; Pyruvaldehyde polymer; CAS-78-98-8; BRN 0906750; RTR-025193; CCRIS 1741; EINECS 201-164-8; AN-23972; Tox21_303931; Methylglyoxal solution 40% in water; LS-139762; 1-Ketopropionaldehyde; AC1Q1JBB; acetylformaldehyde; Pyruvaldehyde solution, 40 wt. % in H2O; Propanal, 2-oxo- (9CI); C00546; KS-0000006N; NSC-626580; EC 201-164-8; CHEMBL170721; FEMA No. 2969; Propionaldehyde, 2-oxo-; NSC133493; CTK2H7121; GTPL6303; AB00820; AKOS000119318; DB03587; 1,2-Propanedione; acetyl formaldehyde; Acetylformyl; BP-20618; NSC-79019; 4-01-00-03631 (Beilstein Handbook Reference); Pyruvaldehyde (8CI); SC-74380; alpha-Ketopropionic aldehyde; DSSTox_GSID_21628; WLN: VHV1; AC1Q1JBA; .alpha.-Ketopropionaldehyde; 2-oxo-propanal; Glyoxal, methyl; DTXSID0021628; NSC79019; LTBB001468; DSSTox_CID_1628; AIJULSRZWUXGPQ-UHFFFAOYSA-N; 722KLD7415; NSC 79019; J-510228; Pyruvic Aldehyde (40% solution); HSDB 7510; 129393-62-0; 2-keto Propionaldehyde; NSC 337790; KB-60264; MFCD00006960; NSC 626580; UNII-722KLD7415; METHYL GLYOXAL, 30% IN WATER; methyl-glyoxal; Acetalformaldehyde; 2-Oxopropionaldehyde; KM1949; ZINC1532681; NSC133492; NCGC00356972-01; MCULE-2718961814; AC1L1A8H; MolPort-001-769-006; Epitope ID:143620; Pyruvic aldehyde solution, 35-45 wt. % in water 25g; 194597AC-5BFC-42EA-B6C8-DA2E5FAA13AF; Methylglyoxal solution, ~40% in H2O; CHEBI:17158	C3H4O2	72.06 g/mol	CC(=O)C=O
TCMBANKIN036885	protopanaxadiol		C30H52O3	460.7 g/mol	CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)O)C)C)O)C)O)C

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000023	Skin and Connective Tissue Diseases; Immune System Diseases	Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI000054	Nervous System Diseases; Mental Disorders	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI000166	-	-	Neoplastic Process	disease
TCMBANKDI002606	Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases	Abnormality of the respiratory system	Sign or Symptom	phenotype
TCMBANKDI002974	Neoplasms	-	Neoplastic Process	disease
TCMBANKDI003101	Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases	-	Neoplastic Process	disease
TCMBANKDI003248	Nutritional and Metabolic Diseases; Endocrine System Diseases	Abnormality of metabolism/homeostasis; Abnormality of the endocrine system	Disease or Syndrome	disease
TCMBANKDI003411	-	-	Disease or Syndrome	disease
TCMBANKDI006211	-	-	Molecular Function	phenotype
TCMBANKDI006612	Neoplasms; Female Urogenital Diseases and Pregnancy Complications	Abnormality of the genitourinary system; Neoplasm	Neoplastic Process	disease
TCMBANKDI011174	Infections	-	Disease or Syndrome	group
TCMBANKDI011758	-	-	Laboratory Procedure	phenotype
TCMBANKDI012932	Infections; Immune System Diseases	-	Disease or Syndrome	group
TCMBANKDI014088	Respiratory Tract Diseases; Cardiovascular Diseases	Abnormality of the respiratory system; Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI014690	-	-	Laboratory Procedure	phenotype
TCMBANKDI015485	Mental Disorders	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI017673	-	-	Clinical Attribute	phenotype
TCMBANKDI018731	Digestive System Diseases	Abnormality of the digestive system	Disease or Syndrome	disease
TCMBANKDI020257	Cardiovascular Diseases	-	Disease or Syndrome	disease
TCMBANKDI022433	Respiratory Tract Diseases; Cardiovascular Diseases	-	Disease or Syndrome	disease
TCMBANKDI025090	Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases	Abnormality of the respiratory system	Sign or Symptom	phenotype
TCMBANKDI027451	-	-	Disease or Syndrome	disease
TCMBANKDI028459	Congenital, Hereditary, and Neonatal Diseases and Abnormalities	Abnormality of the digestive system; Abnormality of the cardiovascular system; Growth abnormality	Congenital Abnormality	disease
TCMBANKDI032498	Nutritional and Metabolic Diseases	Abnormality of metabolism/homeostasis; Abnormality of the endocrine system	Disease or Syndrome	disease